Ngā hua rapu - David Capper

Whakamahine hua
  1. 1
    <scp>WHO</scp> 2016 Classification of gliomas

    <scp>WHO</scp> 2016 Classification of gliomas mā Pieter Wesseling, David Capper

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Invited Review: DNA methylation‐based classification of paediatric brain tumours

    Invited Review: DNA methylation‐based classification of paediatric brain tumours mā Eilís Pérez, David Capper

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach

    Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach mā David Capper, Michel Mittelbronn, Richard Meyermann, Jens Schittenhelm

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT

    Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT mā Matthias S. Dettmer, Anja Schmitt, Hans C. Steinert, David Capper, Holger Moch, Paul Komminoth, Aurel Perren

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E

    Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E mā Ildikó Mesteri, Günther Bayer, Jochen Meyer, David Capper, Sebastian F. Schoppmann, Andreas von Deimling, Peter Birner

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    PCR‐ and Restriction Endonuclease‐Based Detection of <i>IDH1</i> Mutations

    PCR‐ and Restriction Endonuclease‐Based Detection of <i>IDH1</i> Mutations mā Jochen Meyer, Stefan Pusch, Jörg Balß, David Capper, Wolf Mueller, Arne Christians, Christian Hartmann, Andreas von Deimling

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics

    Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics mā Salvatore Benfatto, Martin Sill, David Jones, Stefan M. Pfister, Felix Sahm, Andreas von Deimling, David Capper, Volker Hovestadt

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Detection of 2‐Hydroxyglutarate in Formalin‐Fixed Paraffin‐Embedded Glioma Specimens by Gas Chromatography/Mass Spectrometry

    Detection of 2‐Hydroxyglutarate in Formalin‐Fixed Paraffin‐Embedded Glioma Specimens by Gas Chromatography/Mass Spectrometry mā Felix Sahm, David Capper, Stefan Pusch, Jörg Balß, Arend Koch, Claus‐Dieter Langhans, Jürgen G. Okun, Andreas von Deimling

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Management of pineal region tumors in a pediatric case series

    Management of pineal region tumors in a pediatric case series mā Matthias Schulz, Melissa Afshar-Bakshloo, Arend Koch, David Capper, Pablo Hernáiz Driever, Anna Tietze, Arne Grün, Ulrich‐Wilhelm Thomale

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on <scp>DNA</scp> methylation

    Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on <scp>DNA</scp> methylation mā Maximilian Leitheiser, David Capper, Philipp Seegerer, Annika Lehmann, Ulrich Schüller, Klaus‐Robert Müller, Frederick Klauschen, Philipp Jurmeister, Michael Bockmayr

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer

    BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer mā David Capper, Anita Y. Voigt, Gergana Bozukova, Aysel Ahadova, Philipp Kickingereder, Andreas von Deimling, Magnus von Knebel Doeberitz, Matthias Kloor

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    2‐Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size

    2‐Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size mā David Capper, Matthias Simon, Claus‐Dieter Langhans, Jürgen G. Okun, Jörg C. Tonn, Michael Weller, Andreas von Deimling, Christian Hartmann

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution

    A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution mā Tianyu Zhu, Jacklyn Liu, Stephan Beck, Pan Sun, David Capper, Matt Lechner, Chrissie Thirlwell, Charles E. Breeze, Andrew E. Teschendorff

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients

    Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients mā Christine Jungk, Despina Chatziaslanidou, Rezvan Ahmadi, David Capper, Justo Lorenzo Bermejo, Janina Exner, Andreas von Deimling, Christel Herold‐Mende, Andreas Unterberg

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre

    Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre mā Zane Jaunmuktane, David Capper, David Jones, Daniel Schrimpf, Martin Sill, Monika Dutt, Nirosha Suraweera, Stefan M. Pfister, Andreas von Deimling, Sebastian Brandner

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity

    High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity mā Katja Bender, Eilís Pérez, Mihaela Chirica, Julia Onken, Johannes Kahn, Winfried Brenner, Felix Ehret, Philipp Euskirchen, Arend Koch, David Capper, David Kaul

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice

    Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice mā Bjarne Daenekas, Eilís Pérez, Fabio Boniolo, Sabina Ştefan, Salvatore Benfatto, Martin Sill, Dominik Sturm, David Jones, David Capper, Marc Zapatka, Volker Hovestadt

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Real-world experience with TTFields in glioma patients with emphasis on therapy usage

    Real-world experience with TTFields in glioma patients with emphasis on therapy usage mā Claudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, David Wasilewski, Bastian Gastl, Martin Misch, David Capper, David Kaul, Lars Bullinger, Peter Vajkoczy, Julia Onken

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors

    Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors mā David Capper, Susanne Weißert, Jörg Balß, Antje Habel, Jochen Meyer, Diana Jäger, Ulrike Ackermann, Claudia Tessmer, Andrey Korshunov, Hanswalter Zentgraf, Christian Hartmann, Andreas von Deimling

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors

    The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors mā Alon D. Altman, Gregg Nelson, Prafull Ghatage, John B. McIntyre, David Capper, Pamela Chu, Jill Nation, Anthony N. Karnezis, Guangming Han, Steve E. Kalloger, Martin Köbel

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: